On the week of the 17th of February, MTRC published one post related to the involvement of industry in the reimbursement processes in Europe. Follow us on Instagram on @mtrc.market.access

Axonics sacral neuromodulation would be an option for people with symptoms of the overactive bladder who have not responded to conservative treatments or drug therapy. The Axonics could save the NHS around £6,200 per patient if the device lasts more than six years. Consultations are open to the stakeholders until March 13, 2020.

In late January 2020, the Charité - Universitätsmedizin Berlin and health insurance provider Barmer have signed an integrated care contract for the telemedical management of patients with chronic heart failure. Also, the benefit assessment process at the Federal Joint Committee (G-BA) has already started, and a result is expected in spring 2021.

On January 31, 2020, the non-statutory HTA body, Swiss Medical Board, published the results of the report in which they compared the surgical and non-surgical treatment of rotator cuff tears. Though the surgery is more effective, the traditional treatment demonstrated better cost-benefit results. Thus, the Swiss Medical Board recommends the rotator cuff surgery with limitations.

We have released the interview on the Market Access Insider channel on Youtube. The interview covered the role and activities of patient advocacy groups in Italy, typical issues facing by the patient organizations, role of patient organizations in development of the LEA catalog in Italy, access to stoma care across Italian regions, the importance of setting up patient registries to facilitate access to medical technologies.

NICE published a draft Diagnostic guideline on the Reveal LINQ monitor. The monitor can be recommended for routine adoption under certain clinical criteria. The expected publication date of the final guideline is 27 May 2020.

The French High Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in January 2020 concern various types of devices, mostly for cardiovascular and orthopaedic devices, and medial aids. A total of 29 decisions were made.

On the week of the 10th of February, MTRC published several posts related to the innovation funding schemes for medical devices in Europe, and the 2020 decisions for the innovation funding in Germany (NUB). Follow us on Instagram on @mtrc.market.access

The Italian association of medical technology manufacturers, CONFINDUSTRIA dispositivi medici, published the results of a study in which they studied the average time the supplier of medical devices has to wait to get an invoice paid by the Italian hospitals. The differences vary between 35 days and 504 days.

On February 1, 2020, an additional test was added to the newborn screening, performed 2-3 days after birth. Severe combined immunodeficiency (SCID) is thus the 18th disease for which newborns are screened in Denmark.

At the end of January 2020, the entity managing the DRG system in Switzerland, SwissDRG, has published the data collection forms for SwissDRG 2020 (2019 data). Furthermore, an explanation about the coding of “Aortic stent graft (stent prosthesis)” has been released.

In January 2020, the National Institute for Health and Care Excellence (NICE) published only three new interventional procedure guidance (for reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues, fetoscopic and open prenatal repair for open neural tube defects in the fetus).